TEAM AND COLLABORATION
The people behind Yolia
Yolia team
Alberto Osio, MBA
CEO
Background in international sales & marketing with Hormel, MBA from Sloan School of Management at MIT and Co-founder of Angel Ventures Mexico
Ken Kenyon, M.D.
Ophthalmology USA
Adjunct Clinical Scientist at Schepens Eye Research Institute (Harvard) and Clinical Professor of Ophthalmology at Tufts University School of Medicine
Raul Suarez, M.D.
Ophthalmology Mexico
Ex President of the Mexican Academy of Ophthalmology, investigator and Director of the Vision Institute in Mexico City
Eduardo Osio, MBA
Operations
Former Logistics Director for Herdez Corporation (MEX:HERDEZ), MBA from IPADE Business School
José Luis Monroy, OD.
Sales & Marketing
Former General Manager for CooperVision and former Commercial Director for Bausch + Lomb and Ciba Vision. Current President of the Latin American Contact Lens & Cornea Association
David Castillejos, MD
Ophthalmologist
Co-founder of Castillejos Eye Institute. Completed his ophthalmology residency at the University of Montreal and a retina fellowship at the University of Toronto. His clinical and research experience includes eye disease, refractive surgery and intraocular lenses.
Yolia advisors
Robert Langer
Honorary Scientific Advisor
Institute Professor at MIT, a pioneer in controlled drug delivery, biomaterials and tissue engineering, and a co-founder of Moderna. Serves Yolia as Honorary Scientific Advisor.
Alexander Klibanov, PhD
Novartis Professor of Chemistry, Emeritus, at MIT. His research spans enzymatic catalysis, antimicrobial materials, and stabilization and delivery of biopharmaceuticals.
Praveen Tyle, PhD
CEO of Orion Biotechnology, Chairman of Kiora Pharmaceuticals and founder of Potens Pharmaceuticals. Brings more than 40 years of pharmaceutical and biotechnology experience spanning drug development, innovation and business leadership.
Henry B. Weil
Senior Lecturer in Technological Innovation, Entrepreneurship, and Strategic Management at MIT Sloan. His work addresses business strategy, competitiveness, and technology industries. Previously president and CEO of Pugh-Roberts Associates.
John Rinehart, OD
Distinguished orthokeratologist
Strategic partners
